Design and analysis of randomized clinical trials for onchocerciasis, loiasis and mansonellosis: A systematic review

by Lotola Mougeni F, Bofill Roig M, Hübner MP, Klarmann-Schulz U, Lenz B, Specht S, Posch M, Zehetmayer S. PLOS Neglected Tropical Diseases 2026, 20(2): e0013992. doi:10.1371/journal.pntd.0013992

Summary: Filarial diseases such as onchocerciasis, loiasis, and mansonellosis affect millions of people. However, conducting and analyzing trials of potential treatments can be difficult because patient numbers are often small and the measurements used to evaluate treatment success can vary widely. The authors of this study systematically reviewed randomized clinical trials from the past 25 years, examining the design, analysis of the results, and statistical methods applied. Although many were well planned, there was substantial variation including in primary outcome measures, duration of follow-up, and data analysis methods. In several trials, essential details were insufficiently reported, limiting comparisons across studies. Clearer, more consistent reporting and the use of advanced statistical methods would make such trials more reliable and easier to interpret.

Access article

The post Design and analysis of randomized clinical trials for onchocerciasis, loiasis and mansonellosis: A systematic review first appeared on DNDi.

Ajude os pacientes negligenciados

Até o momento, desenvolvemos nove tratamentos para doenças negligenciadas, salvando milhões de vidas. Temos o objetivo de disponibilizar 25 novos tratamentos em nossos primeiros 25 anos. Você pode nos ajudar!

Organização internacional, sem fins lucrativos, que desenvolve tratamentos seguros, eficazes e acessíveis para os pacientes mais negligenciados.

DNDi Global

Entre em contato

DNDi pelo mundo

Apoie a DNDi

Faça uma doação!

Trabalhe conosco

Oportunidades

Exceto para imagens, filmes e marcas registradas que estão sujeitos aos Termos de Uso da DNDi, o conteúdo deste site está licenciado sob uma Licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license.